Abstract
A controlled double-blind study of the effect of dipyridamole was performed in 169 patients with established cerebral vascular disease. A dose of 400 mg. was used initially, given daily for an average of 14 months; the dose was then increased to 800 mg. daily for a further average period of 11 months. When the incidence of cerebral ischaemic episodes during treatment was compared in the drug-treated and placebo-treated groups no significant difference was found.
Full text
PDF

Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Afonso S., O'Brien G. S. Enhancement of coronary vasodilator action of adenosine triphosphate by dipyridamole. Circ Res. 1967 Apr;20(4):403–408. doi: 10.1161/01.res.20.4.403. [DOI] [PubMed] [Google Scholar]
- CHIBA T. EXPERIMENTAL STUDIES ON THE EFFECTS OF PERSANTIN WITH NORMAL AND GO-DOGS. Bull Osaka Med Sch. 1963 Apr;9:106–128. [PubMed] [Google Scholar]
- DEGRAFF A. C., LYON A. F. Evaluation of dipyridamole (Persantin). Am Heart J. 1963 Mar;65:423–424. doi: 10.1016/0002-8703(63)90018-8. [DOI] [PubMed] [Google Scholar]
- Emmons P. R., Harrison M. J., Honour A. J., Mitchell J. R. Effect of a pyrimidopyrimidine derivative on thrombus formation in the rabbit. Nature. 1965 Oct 16;208(5007):255–257. doi: 10.1038/208255a0. [DOI] [PubMed] [Google Scholar]
- Emmons P. R., Harrison M. J., Honour A. J., Mitchell J. R. Effect of dipyridamole on human platelet behaviour. Lancet. 1965 Sep 25;2(7413):603–606. doi: 10.1016/s0140-6736(65)90515-5. [DOI] [PubMed] [Google Scholar]
- FAM W. M., RAGHEB S., HOESCHEN R. J. AUGMENTATION OF INTERCORONARY ANASTOMOSIS BY LONG-TERM ADMINISTRATION OF A VASODILATOR DRUG, DIPYRIDAMOLE (PERSANTIN). Can Med Assoc J. 1964 Apr 18;90:970–973. [PMC free article] [PubMed] [Google Scholar]
- FOULDS T., MACKINNON J. Controlled double-blind trial of "persantin" in treatment of angina pectoris. Br Med J. 1960 Sep 17;2(5202):835–835. doi: 10.1136/bmj.2.5202.835. [DOI] [PMC free article] [PubMed] [Google Scholar]
- LAUDAHN G. [The effect of Persantin on heart muscle sarcosomes]. Experientia. 1961 Sep 15;17:415–416. doi: 10.1007/BF02157978. [DOI] [PubMed] [Google Scholar]
- LEIBERMAN A., GUGLIELMELLI S. PERSANTIN-- A DOUBLE BLIND STUDY. Angiology. 1964 Jun;15:290–292. doi: 10.1177/000331976401500608. [DOI] [PubMed] [Google Scholar]
- Meesmann W., Bachmann G. W. Pharmakodynamisch induzierte Entwicklung von Koronar-Kollateralen in Abhängigkeit von der Dosis. Arzneimittelforschung. 1966 Apr;16(4):501–509. [PubMed] [Google Scholar]
- NEWHOUSE M. T., MCGREGOR M. LONG TERM DIPYRIDAMOLE THERAPY OF ANGINA PECTORIS. Am J Cardiol. 1965 Aug;16:234–237. doi: 10.1016/0002-9149(65)90478-9. [DOI] [PubMed] [Google Scholar]
- SIESS M. [Function and energy metabolism of the exhausted heart muscle under the effects of 2,6-bis-(diethanolamino)-4,8-dipiperidino-pyrimido-(5,4-d)-pyrimidine]. Arzneimittelforschung. 1962 Jul;12:683–691. [PubMed] [Google Scholar]
- SOLOFF L. A., GIMENEZ J. L., WINTERS W. L., Jr Experimental and clinical observations on 2,6-bis-(diethanolamino)-4,8-dipiperidino-pyrimido-(5,4-d) pyrimidine (Persantin). Am J Med Sci. 1962 Jun;243:783–789. doi: 10.1097/00000441-196206000-00009. [DOI] [PubMed] [Google Scholar]
- Sbar S., Schlant R. C. Dipyridamole in the treatment of angina pectoris. A double-blind evaluation. JAMA. 1967 Sep 11;201(11):865–867. [PubMed] [Google Scholar]
- Sullivan J. M., Harken D. E., Gorlin R. Pharmacologic control of thromboembolic complications of cardiac-valve replacement. A preliminary report. N Engl J Med. 1968 Sep 12;279(11):576–580. doi: 10.1056/NEJM196809122791104. [DOI] [PubMed] [Google Scholar]
- Sullivan J. M., Kagnoff M. F., Gorlin R. Reduction of platelet adhesiveness in patients with coronary artery disease. Am J Med Sci. 1968 May;255:292–295. doi: 10.1097/00000441-196805000-00004. [DOI] [PubMed] [Google Scholar]
- VINEBERG A. M., CHARI R. S., PIFARRE R., MERCIER C. The effect of persantin on intercoronary collateral circulation and survival during gradual experimental coronary occlusion. A preliminary report. Can Med Assoc J. 1962 Aug 18;87:336–345. [PMC free article] [PubMed] [Google Scholar]
- ZION M. M., BRADLOW B. A. A controlled clinical trial of 'persantin' (R A 8) in angina pectoris. S Afr Med J. 1961 Jan 7;35:11–13. [PubMed] [Google Scholar]